The ethics of a clinical trial when the protocol clashes with international guidelines.
Ontology highlight
ABSTRACT: Due to their nature and complexity, clinical trials often take some time to launch after the protocol has been designed and ethics approval obtained. During this time, there may be changes in international treatment guidelines and recommendations that result in a conflict between study protocol and recommended international best practice. Here, we describe the situation that arose in a pharmacokinetic study on the use of two different doses of rifabutin in patients with human immunodeficiency virus-associated tuberculosis who initiated antiretroviral therapy (ART) with a lopinavir-ritonavir-based regimen in South Africa and Viet Nam. The study protocol specified that ART should be started 10 weeks after the start of anti-tuberculosis treatment. The study in South Africa was approved in Jun
SUBMITTER: Lan NT
PROVIDER: S-EPMC4463098 | biostudies-literature | 2013 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA